Table 5.
Resistance Pattern | Phenotypic resistance | Number of resistant EIEC isolates (%) |
---|---|---|
I | AMP | 2 (15.3%) |
II | AMP, SXT | 1 (7.6%) |
III | AMP, SXT, TET | 1 (7.6%) |
IV | AMP, SXT, TET, CTX, CRO, GM | 2 (15.3%) |
V | AMP, SXT, TET, CTX, CRO, CAZ, GM | 1 (7.6%) |
VI | AMP, SXT, TET, CTX, CRO, CAZ, GM, CO | 1 (7.6%) |
VII | AMP, SXT, TET, CTX, CRO, CAZ, ATM, AK | 2 (15.3%) |
VIII | AMP, SXT, TET, CTX, CRO, CAZ, ATM, GM, AK | 1 (7.6%) |
IX | AMP, SXT, TET, CTX, CRO, CAZ, ATM, GM, IMP | 2 (15.3%) |
CTX: cefotaxime, CRO: ceftriaxone, CAZ: ceftazidime, AK: amikacin , IMP: imipenem, CO:colistin sulfate, GM: gentamicin, ATM: aztreonam, SXT: Sulfamethoxazole-trimethoprim, TET: tetracycline, AMP: ampicillin